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Pseudomonas aeruginosa Lifestyle:
A Paradigm for Adaptation, Survival,
and Persistence
M. Fata Moradali †, Shirin Ghods and Bernd H. A. Rehm*
Institute of Fundamental Sciences, Massey University, Palmerston North, New Zealand
Pseudomonas aeruginosa is an opportunistic pathogen affecting immunocompromised
patients. It is known as the leading cause of morbidity and mortality in cystic fibrosis
(CF) patients and as one of the leading causes of nosocomial infections. Due to a
range of mechanisms for adaptation, survival and resistance to multiple classes of
antibiotics, infections by P. aeruginosa strains can be life-threatening and it is emerging
worldwide as public health threat. This review highlights the diversity of mechanisms
by which P. aeruginosa promotes its survival and persistence in various environments
and particularly at different stages of pathogenesis. We will review the importance
and complexity of regulatory networks and genotypic-phenotypic variations known as
adaptive radiation by which P. aeruginosa adjusts physiological processes for adaptation
and survival in response to environmental cues and stresses. Accordingly, we will review
the central regulatory role of quorum sensing and signaling systems by nucleotide-based
second messengers resulting in different lifestyles of P. aeruginosa. Furthermore, various
regulatory proteins will be discussed which form a plethora of controlling systems acting
at transcriptional level for timely expression of genes enabling rapid responses to external
stimuli and unfavorable conditions. Antibiotic resistance is a natural trait for P. aeruginosa
and multiple mechanisms underlying different forms of antibiotic resistance will be
discussed here. The importance of each mechanism in conferring resistance to various
antipseudomonal antibiotics and their prevalence in clinical strains will be described.
The underlying principles for acquiring resistance leading pan-drug resistant strains will
be summarized. A future outlook emphasizes the need for collaborative international
multidisciplinary efforts to translate current knowledge into strategies to prevent and treat
P. aeruginosa infections while reducing the rate of antibiotic resistance and avoiding the
spreading of resistant strains.
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INTRODUCTION
Pseudomonas aeruginosa is a Gram-negative and ubiquitous environmental bacterium. It is an
opportunistic human pathogen capable of causing a wide array of life-threatening acute and chronic
infections, particularly in patients with compromised immune defense. It has been of particular
importance since it is the main cause of morbidity and mortality in cystic fibrosis (CF) patients and
one of the leading nosocomial pathogens affecting hospitalized patients while being intrinsically
resistant to a wide range of antibiotics.
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P. aeruginosa strains possess large genomes (∼5–7 Mbp).
Their metabolic capacity is extensive as exemplified by their
ability to produce multiple secondary metabolites and polymers
as well as their ability to use various carbon sources and
electron acceptors. The repertoire of P. aeruginosa genes which
are substantially conserved suggest the highest proportion of
regulatory genes and networks observed in known bacterial
genomes and is foundational to respond and adapt to
diverse environments (Stover et al., 2000; Mathee et al.,
2008; Frimmersdorf et al., 2010). The ubiquitous presence of
P. aeruginosa as well as its prevalence and persistence in
clinical settings including intrinsic resistance to therapeutics are
attributed to its extraordinary capability of survival by recruiting
an arsenal of responsive mechanisms.
In the present review, we have attempted to summarize
the diversity of these mechanisms causing the versatility of
P. aeruginosa to adapt and thrive in unfavorable conditions
particularly during pathogenesis. To this end, we will describe
the clinical importance of P. aeruginosa followed by the well-
characterized and most recent findings about key strategic
adaptation mechanisms including quorum sensing (QS),
motility-sessility switch, biofilm formation, antibiotic resistance
mechanisms, adaptive radiation for persistence, stringent
response and persisters, and the CRISPR-Cas systems. Recent
findings on adaptive mechanisms will be set into context of the
overall physiology of P. aeruginosa by also depicting on future
research needs.
CLINICAL IMPORTANCE
The CF patients suffer from a multisystem disease due
to inheritable genetic defects in the CF transmembrane
conductance regulator (CFTR) gene. However, the recurrence of
bacterial infections in the abnormal mucus layers is the main
cause of morbidity and mortality of CF patients (Khan et al.,
1995; Rosenfeld et al., 2001). The CFTR regulator is responsible
for regulating the transport of electrolytes and chloride across
epithelial cell membranes to maintain normal mucus properties
and homeostasis. Therefore, the loss of function of the CFTR
protein results in abnormally thick, dehydrated and sticky
mucus layers in the lung (Flume and Van Devanter, 2012).
Hence, the CF patients are largely susceptible to respiratory
infections by P. aeruginosa from infancy. When they are under
a year old, almost 30% of CF infants can acquire initial
P. aeruginosa strains from the environment leading to acute
infections. This rate increases to about 50% by the age of 3 years
while mucoid phenotypes causing chronic infections have been
reported emerging at the age of 3 to16 years (median of 13 years)
(Rehm et al., 1994; da Silva et al., 2013; Jones et al., 2016). P.
aeruginosa will adapt to CF airways and persist as overwhelming,
predominant and ineradicable infections to the end of patients’
life in almost 70% of adults (Döring et al., 2000).
Furthermore, P. aeruginosa is also largely associated with
hospital acquired infections including ventilator-associated
pneumonia, central line-associated bloodstream infection,
urinary catheter-related infection, and surgical/transplantation
infections (Cardo et al., 2004; Nathwani et al., 2014; Trubiano
and Padiglione, 2015). The International Nosocomial Infection
Control Consortium reported that P. aeruginosa nosocomial
infections have become a worldwide healthcare issue (Rosenthal
et al., 2016). A cohort study reported that P. aeruginosa
had the highest burden of healthcare-acquired infections
in European intensive care units (Lambert et al., 2011).
In the United States healthcare-associated P. aeruginosa
infections were estimated to contribute to 51,000 cases each
year (Eurosurveillance Editorial Team, 2013). P. aeruginosa
is prevalent in healthcare settings because it is a common
companion of patients under medical care and also it can
survive on abiotic and biotic surfaces such as medical equipment
resisting disinfection methods while being transmissible from
patient-to-patient (Russotto et al., 2015).
P. aeruginosa infections are becoming more difficult to treat
because this bacterium is naturally resistant to many antibiotics
and the number of multidrug- and pan-drug-resistant strains
is increasing worldwide. Strains have been reported which
are resistant to almost all class of commonly used antibiotics
including aminoglycosides, cephalosporins, fluoroquinolones,
and carbapenems (Hancock and Speert, 2000; Poole, 2011;
Eurosurveillance Editorial Team, 2013). In the United States
about 13% of P. aeruginosa infections are caused by multidrug
resistant strains (Eurosurveillance Editorial Team, 2013).
P. aeruginosa utilizes sophisticated genotypic events to
support various phenotypes and molecular mechanisms required
for survival during pathogenesis and antibiotic treatment.
Therefore, at initial stages of CF lung colonization, a
large number of virulence and intrinsic antibiotic resistance
mechanisms mediate survival. After infection, bacteria are
exposed to inflammatory responses including oxidative stress
followed by treatment with antibiotics (Furukawa et al., 2006;
Turner et al., 2014). These environmental stress factors induce
the expression of different sets of genes enabling P. aeruginosa
to adapt and switch to persisting and resistant phenotypes,
while becoming less virulent, such as upon formation of
mucoid biofilms (MacDougall et al., 2005; Poole, 2012; Gellatly
and Hancock, 2013). Due to the existence of an arsenal of
molecular mechanisms conferring resistance to multiple classes
of antibiotics, therapeutic options are increasingly limited for
treatment of infections, while the number of infection incidences
and multi-drug resistance strains are increasing.
CENTRAL REGULATORY ROLE OF
QUORUM SENSING (QS) FOR VIRULENCE
AND ADAPTATION
Communication between individual cells using specific chemical
signals is a well-known capability of bacteria and is called
quorum sensing. Indeed, QS controls social behavior of bacteria
by multiple interconnected signaling pathways (LaSarre and
Federle, 2013). It allows bacterial communities to regulate a
variety of biological processes important for bacterial adaptation
and survival. Basically, this phenomenon relies on regulating
the expression of specific sets of genes in response to a
critical threshold of signaling molecules known as autoinducers
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(AIs). QS will mediate population density dependent collective
responses and is therefore beneficial for community survival.
A study showed that cells’ responses to QS signals and the
corresponding gene expression profile is heterogeneous within
a given community leading to increasing fitness and chance of
survival (Grote et al., 2015).
During pathogenesis P. aeruginosa QS plays a critical
role for survival and colonization by coordinating phenotypic
alterations at early stages of infection i.e., after attachment
(González and Keshavan, 2006). The progress of acute to
chronic infection is critically influenced by QS-dependent
gene expression. More than 10% of P. aeruginosa genes
are regulated by QS. These genes are mainly involved in
virulence factor production, motility, motility-sessility switch
and biofilm development, antibiotic resistance mechanisms and
the adjustment of metabolic pathways for stress responses
(Venturi, 2006; Williams and Camara, 2009; Barr et al., 2015).
The role of QS in each physiological adaptation will be discussed
below.
Molecular Mechanisms Underlying QS
As shown in Figure 1, four main pathways of QS dependent
signaling exist in P. aeruginosa. These constitute a hierarchal
network mediating integration of multiple signals via cross-
talk between the QS signaling pathways. The most recently
discovered IQS signaling pathway is less understood and its
integration and impact on gene expression still needs to be
unraveled. It was previously proposed that the IQS molecule
(an aeruginaldehyde) is the product of enzymatic activity of
proteins encoded by ambBCDE genes (Lee et al., 2013), while new
findings showed the IQSmolecule is a byproduct of the pyochelin
biosynthesis pathway and AmbBCDE proteins are responsible
for the biosynthesis of the toxin L-2-amino-4-methoxy-trans-3-
butenoic acid (AMB) (Ye et al., 2014; Rojas Murcia et al., 2015;
Sun et al., 2016).
In regard to the other three QS pathways, each system consists
of at least two major functional elements; the first category of
proteins (i.e., LasR, RhlR, or PqsR, respectively) is activated upon
sensing specific autoinducers (AIs) and acts as transcriptional
activator for genes encoding the second tier proteins, the cognate
AI synthases (i.e., LasI, RhlI, and PqsABCDH, respectively).
These activation steps constitute a fine-tuned circuit by which
the synthesized AIs are exported outside the cells followed
by being imported again (Figure 1). Transportation of these
signals is not well understood, but it is proposed as being
mediated by free diffusion, membrane transporters such as
specific eﬄux systems or membrane vesicles (Mashburn and
Whiteley, 2005; Martinez et al., 2009; Alcalde-Rico et al., 2016).
Beyond this regulatory circuit the activated AI-sensing proteins
act as transcriptional factors for activating the expression of other
set of genes such as virulence genes in response to environmental
stimuli (Figure 1). Transcriptional activation occurs via binding
to conserved las/rhl boxes acting as operators residing upstream
of these genes (González-Valdez et al., 2014; Lee and Zhang,
2015; Banerjee and Ray, 2016; Papenfort and Bassler, 2016). In
the hierarchy of this network, LasR resides at the top of the
cascade and along with RhlRmediates QS signaling at early stages
of exponential growth phase while the PQS signaling pathway
is active at late exponential growth phase (Choi et al., 2011).
As abovementioned, cumulative and cell density-dependent
production of AIs is required for reaching a specific threshold
triggering collective responses by individual cells.
QS-Controlled Virulence Factors and
Stress Responses
Production of virulence factors is a survival strategy for
pathogens to evade the host immune defense resulting in
progression of pathogenesis particularly at early stage of
colonization and acute infection. A large number of virulence
factors including cell-associated or secreted compounds, both
low and high molecular weight compounds have been reported
as important in colonization and establishment of infections by
P. aeruginosa. Although they play a critical role in promoting
bacterial growth and survival, they can cause devastating injuries
to the host tissues and impair the immune responses. QS deficient
mutants cause considerably less tissue damage and pathological
changes during infections due to a significant decrease in the
virulence and cytotoxicity (Nelson et al., 2009; Feng et al., 2016).
Production of many virulence factors is metabolically costly
and requires community involvement. Hence, they are mainly
under the regulatory control of theQS systems (Figure 1,Table 1;
Whiteley et al., 1999; Diggle et al., 2002; Wagner et al., 2003;
García-Contreras, 2016).
Analysis of bronchial secretions of CF patients during
different stages of pulmonary exacerbations showed that QS
upregulates the expression of genes involved in the production
of some destructive virulence factors such as proteases (elastase,
alkaline protease), phenazines (pyocyanin), toxins (exotoxin A),
rhamnolipids and hydrogen cyanide (Jaffar-Bandjee et al., 1995;
Lee and Zhang, 2015). Production of these toxic compounds is
destructive to the host cells/tissues by impairing permeability
barrier and by inhibiting protein production promoting cell
death.
Recent findings suggested a correlation between systemic
concentrations of some QS signaling molecules with the clinical
status of pulmonary exacerbation and at least some QS signaling
molecules were elevated at the start of either pulmonary
exacerbation or antibiotic treatment when assessing different
biofluids (Barr et al., 2015). In conclusion, virulence factors
assist bacteria in colonization and survival aligned with worsened
clinical course of infections. Thus, QS can determine the degree
of pathological damages and clinical stages of infections in
response to environmental factors.
Pathogenesis encompasses various stresses such as
host immune factors, bacterial interspecies competition,
phosphate/iron depletion and starvation. QS systems and
production of some virulence factors mediate appropriate
responses to these stresses to promote survival and adaptation
(García-Contreras et al., 2015). Here, we provide some examples
of stress responses mediated by the QS systems.
Interferon-γ (IFN-γ) is a crucial cytokine of the human
immune system during infection and it coordinates a wide array
of immunological responses such as up-regulation of pathogen
recognition and the activation of bactericidal effector functions
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FIGURE 1 | Hierarchical QS network in P. aeruginosa and regulation of virulence factors. (A) So far, four pathways including Las, Rhl, Pqs, and IQS have
been understood as mediating QS responses in P. aeruginosa while LasR resides at the top of the cascade. In response to specific stimuli/stress, each pathway
synthesizes cognate autoinducers (AIs) [HSL(3-oxo-C12-homoserine lactone)], BHL (N-butyrylhomoserine lactone or C4-HSL), PQS (2-heptyl-3-hydroxy-4-quinolone)
and IQS [2-(2-hydroxyphenyl)-thiazole-4-carbaldehyde (aeruginaldehyde)]. Export and import of HSL, BHL, and PQS is mediated by the efflux pumps
MexAB-OprM/MexEF-OprN, free diffusion and membrane vesicles, respectively. Question mark indicates unknown pathway of IQS transportation. As fine-tuned
individual circuits, but interconnected (dashed lines), transcriptional factors (i.e., LasR, RhlR, and PqsR) are activated by AIs for upregulating expression of cognate AI
synthases (respectively, LasI, RhlI, PqsABCDH) as well as others such as virulence factor genes. The IQS pathway remains unraveled and the IQS receptor is still
unknown. Various secretion systems mainly type 1 and 2 secretion systems (T1SS/T2SS) and also PvdRT-OpmQ efflux pump mediate the secretion of virulence
factors. (B) QS initiates upon cumulative production of AIs (small colorful circles) by increasing cell density and results in collective responses. AprA, alkaline protease;
Pyd, pyoverdine; PLC, phospholipase C; Tox, toxin A; LasA, LasA elastase; LasB, LasB elastase; HCN, hydrogen cyanide; Pyo, pyocyanin; Rhld, rhamnolipids; Lec A,
lectin A; CM, cytoplasmic membrane; OM, outer membrane.
(Schroder et al., 2004). IFN-γ produced by T-cells was shown
to bind directly to P. aeruginosa OprF, an outer membrane
protein. Upon formation of IFN-γ-OprF complexes the rhl
QS system was activated and resulted in up-regulation of the
expression of lecA (or PA-I lectin) and synthesis of pyocyanin.
The lecA gene encodes the virulence determinant, galactophilic
lectin (or LecA) (Wu et al., 2005) which is cytotoxic and acts
as adhesion factor mediating initiation of host recognition by
P. aeruginosa (Chemani et al., 2009). It induces an increased
permeability of the intestinal and respiratory epithelial cells
enabling cytotoxic exoproducts such as exotoxin A (Laughlin
et al., 2000) to enter host cells (Bajolet-Laudinat et al., 1994).
In addition it also contributes to biofilm development (Diggle
et al., 2006). Furthermore, the QS system has been reported
to mediate a response to the host antimicrobial factor LL-37
by increasing the production of pyocyanin, hydrogen cyanide,
elastase and rhamnolipids (Strempel et al., 2013). The QS-
dependent production of rhamnolipids has a crucial role in
neutralizing the attack of neutrophils due to their necrotic
property (Jensen et al., 2007; Van Gennip et al., 2009).
Recent findings indicated that the LasR and RhlR QS systems,
but not the PQS system, play major roles in adaptation and
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response to environmental stresses such as oxidative, heat, heavy
metal and salt stresses (García-Contreras et al., 2015).
The stress response of P. aeruginosa to the depletion of
phosphate and iron was found to be linked (Slater et al., 2003).
Different studies showed that acquisition of phosphate and iron
are important for survival and pathogenesis of P. aeruginosa
and the expression of cognate genes mediating acquisition of
these elements are upregulated upon interaction with human
respiratory epithelial cells (Frisk et al., 2004; Chugani and
Greenberg, 2007). Various studies unraveled that phosphate-
and iron-deficient conditions can trigger the activation of the
QS system especially via the IQS- or PQS-dependent pathway
leading to boosted activation of central QS and the production
of virulence factors such as rhamnolipids, phenazines, cyanide,
exotoxin A, LasA protease, elastase, and antimicrobials (Kim
et al., 2003; Long et al., 2008; Zaborin et al., 2009; Bains et al.,
2012; Lee et al., 2013; Nguyen et al., 2015). Production of such
virulence factors can increase cytotoxic impact of bacteria on host
tissue and promote pathogen survival.
The recently discovered IQS system which controls the
expression of a large set of virulence factors was shown to be
directly activated by phosphate limitation in P. aeruginosa (Lee
et al., 2013; Lee and Zhang, 2015).
P. aeruginosa QS signaling molecules such as 2-heptyl-
4-hydroxyquinoline (HHQ) and 2-heptyl-4-hydroxyquinoline-
N-oxide (HQNO) can serve as antimicrobial agents against
Staphylococcus aureus which is commonly present during early
stages of pulmonary infections in CF patients. It is proposed
that this antibacterial activity supports the dominance of P.
aeruginosa during the course of infection. Interestingly, this
inter-species competition is linked to the availability of iron
as the depletion of iron potentiates the antistaphylococcal
activity of these metabolites (Nguyen et al., 2016). Also, LasA
is a staphylolytic protease produced by P. aeruginosa and it
is under the regulation of the las QS system (Toder et al.,
1991). Furthermore, when P. aeruginosa was grown together
with the yeast Candida albicans in a mixed biofilm, the QS
system upregulated the production of virulence factors such
as pyoverdine, rhamnolipids and pyocyanin (Trejo-Hernández
et al., 2014).
Oxygen depletion known as hypoxia is another stress factor
for P. aeruginosa during pathogenesis. Hypoxia condition is
influenced by various factors such as reduced ventilation through
viscose layers, chronic inflammation, microbial population and
biofilm formation (Hassett, 1996; Worlitzsch et al., 2002;
Yoon et al., 2002; Alvarez-Ortega and Harwood, 2007; Hassett
et al., 2009). However, P. aeruginosa can survive and grow
under hypoxia to high cell densities. Under hypoxia stress P.
aeruginosa retains the capability of microaerobic respiration,
although occurrence of nitrate respiration was thought to
be possible (Alvarez-Ortega and Harwood, 2007). The QS
regulon expression occurs at low oxygen conditions. Hammond
et al. (2015) unraveled that the 4-hydroxy-2-alkylquinolines
(HAQ)-dependent QS pathway is active during hypoxia via
the ANR protein as the master transcriptional regulator of
anaerobic respiration while it is in the absence of LasR signaling
(Hammond et al., 2015). Under low oxygen tension, the ANR
protein positively regulated the production of the QS signaling
molecule 4-hydroxy-2-alkylquinolines and in turn the regulation
of virulence-related genes could continue via PQS system
(Hammond et al., 2015). Furthermore, under hypoxia stress
the ANR protein and the QS systems cooperatively regulate
hydrogen cyanide biosynthesis (Castric, 1983, 1994; Pessi and
Haas, 2000). This study provided further evidence that low
oxygen-dependent QS inversely correlates with denitrification
i.e., suppresses nitrate respiration (Hammond et al., 2015).
Overall, these examples have provided further insight into the
versatility of P. aeruginosa to adapt to various environmental
conditions by processing signals via integrated and cross-talking
QS pathways resulting in enhanced survival i.e., in a medical
context establishment of acute and chronic infections.
PERSISTENCE AND BIOFILM FORMATION
During acute infection the relationship between pathogen and
host is reciprocally devastating as a variety of cytotoxic molecules
produced by bacteria impair the host cellular processes while
bacteria on the other hand encounter immune system responses
such as production of antimicrobial compounds and reactive
oxygen species, as well as enhanced phagocytosis. In this context,
motile P. aeruginosa display a more virulent phenotype. Various
modes of P. aeruginosamotility such as swimming and swarming
involving flagella and twitching using type 4 pili are associated
with virulent traits (Winstanley et al., 2016). A motile cell is
readily detectable by the host immune system via flagellar and/or
other motility components mediating recognition and induction
of signaling pathways which trigger inflammatory responses and
phagocytosis by murine or human macrophages (Amiel et al.,
2010).
Switching to sessile lifestyle along with lower virulency is a
survival advantage by which many pathogenic bacteria such as
P. aeruginosa evade stresses and adverse conditions. They lose
motility and attach to surfaces and form cellular aggregations
or microcolonies which are embedded in extracellular polymeric
substances (EPS) to protect bacteria from the surrounding
environment. These structures are so called biofilms conferring
an extreme capacity for persistence against phagocytosis,
oxidative stresses, nutrient/oxygen restriction, metabolic waste
accumulation, interspecies competitions, and conventional
antimicrobial agents (Leid, 2009; Olsen, 2015).
Formation of mucoid biofilm by P. aeruginosa is the hallmark
of chronic infections and indicative of disease progression
and long-term persistence. As a consequence, P. aeruginosa
dominates themicrobial community of CF lungs in patients older
than 24 years (McDaniel et al., 2015).
Other P. aeruginosa biofilm associated infections include
chronic wound infection, chronic otitis media, chronic
rhinosinusitis, catheter-associated urinary tract infection,
and contact lens-related keratitis (Römling and Balsalobre,
2012).
Composition of the P. aeruginosa Biofilm
Formed on abiotic and biotic surfaces, the matrix of most
biofilms embedding bacterial cells may account for over 90% of
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dry weight of whole biofilm mass. In fact, this matrix creates
a niche rendering bacteria for intense cell-cell interaction and
communication as well as a reservoir of metabolic substances,
nutrients and energy for promoting growth while shielding
cells from unfavorable conditions (Flemming and Wingender,
2010). The matrix is mainly formed by extracellular polymeric
substances (EPS) which are mainly polysaccharides, proteins,
extracellular DNA (eDNA) and lipids (Strempel et al., 2013).
Major polymers and relevant characteristics are listed in Table 2.
The exopolysaccharides Psl, Pel, and alginate are major
constituents of the P. aeruginosa biofilm matrix involved in
surface adhesion and together with eDNA determine the biofilm
architecture. These EPS play an important role in resistance to
immune responses and antibiotic treatments (Ghafoor et al.,
2011; Gellatly and Hancock, 2013; Strempel et al., 2013). The
differential role of each EPS has been analyzed at each stage of
biofilm development. The various exopolysaccharides and eDNA
were shown to interactively contribute to the biofilm architecture
(Ghafoor et al., 2011). The presence of various EPS exhibiting
different physiochemical properties confers a survival strategy for
increasing the flexibility and stability of biofilms under various
conditions (Jennings et al., 2015).
The Psl polysaccharide is a key element at early stage of biofilm
formation when cells explore surfaces for adhesion (Overhage
et al., 2005). It is anchored around cells in a helical arrangement
initiating biofilm formation by enhancing cell migration, cell-cell
interaction and cell-surface adhesion whereas in mature biofilms
it is located to the periphery of mushroom shaped macrocolonies
(Ma et al., 2009; Zhao et al., 2013). Psl can exist as a fiber-
like matrix requiring type 4 pili-mediated migration of cells
(Wang S. et al., 2013). It protects cells against phagocytosis and
oxidative stress during infection (Mishra et al., 2012). Recent
studies suggested that Psl can provide an instant protective role
against anti-biofilm agents and a broad spectrum of antibiotics
particularly at early stage of biofilm development (Zegans et al.,
2012; Billings et al., 2013). Therefore, Psl provides a survival
advantage during pathogenesis.
Similar to Psl, Pel is important for initiating and maintaining
cell–cell interaction in biofilms (Colvin et al., 2011). Pel and/or
Psl are the primary matrix structural polysaccharides in non-
mucoid P. aeruginosa strains as a predominant environmental
phenotype. However, contribution of Psl and Pel to the
structure of mature biofilms is strain-dependent while both
unique and functionally redundant roles have been reported for
these exopolysaccharides (Colvin et al., 2012). Recent studies
elucidating the chemical structure and biological function of
Pel demonstrated that it is a major structural component of
the biofilm stalk where it cross-links eDNA and structurally
compensates for the absence of Psl in the periphery of mature
biofilm (Jennings et al., 2015). Furthermore, Pel was shown
to protect bacteria against certain aminoglycoside antibiotics
(Colvin et al., 2011).
Overproduction of the exopolysaccharide, alginate, is
characteristic for mucoid phenotype of most clinical isolates from
CF patients. During adaptation to the CF lung environment,
alginate is overproduced and predominantly constitutes the
matrix of mature biofilms conferring a slimy or mucoid
phenotype. Indeed, it is greatly important in biofilm maturation,
structural stability and protection as well as persistence by
shielding P. aeruginosa cells against opsonophagocytosis, free
radicals released from immune cells, and antibiotics used for
treatment (Hay et al., 2009a; Hay I. D. et al., 2013; Strempel et al.,
2013). Some in vitro biofilm studies showed that the composition
of the alginates can greatly influence biofilm characteristics such
as viscoelastic property, bio-volume, cell density and architecture
as well as cell-to-cell interaction, cell aggregation and surface
attachment (Tielen et al., 2005; Moradali et al., 2015).
As abovementioned, eDNA is another important structural
component for biofilm development and along with the Pel
polysaccharide it can be detected within the stalks of mushroom-
shaped macrocolonies. However, eDNA has multifaceted roles
in biofilm formation such as contribution to forming cation
gradients in the matrix via the chelating interaction of highly
anionic DNAwith cations such asMg2+, Ca2+, Mn2+, and Zn2+,
as a nutrient source during starvation, facilitating twitching
motility and coordinating cell movements and conferring
antibiotic resistance (Allesen-Holm et al., 2006; Mulcahy et al.,
2008; Gloag et al., 2013).
Among the proteinaceous biofilm constituents, both flagella
and the type 4 pili are important during maturation of the
biofilm, however, these cell appendages are not commonly
considered as classical matrix components of biofilms. Type 4
pili are important for adhesion and promote initial attachment of
cells to surfaces at early stage of biofilm formation. Together with
eDNA, flagella and the type 4 pili mediate migration required for
the formation of the stalk and the cap in the mushroom-shaped
microcolonies of the mature biofilm (Table 2; Barken et al., 2008;
Mann and Wozniak, 2012).
Central Regulatory Network Governing the
Motility-Sessility Switch
Transition from motility to sessility requires dynamic regulatory
networks at transcriptional, post-transcriptional and post-
translational levels resulting in coordinated timely expression
of hundreds of genes. These events mainly arrest flagella based
motility and the production of virulence factors such as exotoxins
and proteases while positively regulating surface attachment, EPS
production and biofilm maturation (Figure 2).
The small molecule cyclic-3′5′-diguanylic acid (cyclic di-
GMP) is a key signal in post-transcriptional regulation of biofilm
formation. It is an almost ubiquitous second messenger present
in a wide range of bacteria that principally controls motility-
sessility switch. The major determinant for this substantial
phenotypic change is the cellular level of cyclic di-GMP, so that
its elevation triggers biofilm formation while inhibiting motility.
The cyclic di-GMP signaling system is very complex and two
groups of proteins have been identified as main actors. The first
group comprises cyclic di-GMP metabolizing enzymes including
diguanylate cyclases (DGC) (containing GGDEF motif) and
phosphodiesterases (containing EAL or HD-GYP motif) that
respectively synthesize and degrade cyclic di-GMP in cells
(Römling et al., 2013; Valentini and Filloux, 2016). At least
40 such proteins directly synthesize and/or degrade cyclic
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TABLE 2 | Key polymeric substances in P. aeruginosa biofilm formation and development.
Name Identity/Chemistry Precursor(s) Biosynthesis Property References
Psl Exopolysaccharide /
Repeating pentasaccharide containing
D-mannose,
D-glucose and L-rhamnose
GDP-D-mannose,
UDP-D-glucose and
dTDP-L-rhamnose
The pslA-O operon Neutral
charge
Byrd et al., 2009; Colvin
et al., 2012
Pel Exopolysaccharide/
Partially acetylated (1→4) glycosidic
linkages of N-acetylgalactosamine and
N-acetylglucosamine.
UDP-sugar
nucleotide/
uncharacterized
The pelA-G operon Positively
charged
Franklin et al., 2011;
Jennings et al., 2015
Alginate Exopolysaccharide/
O-acetylated 1–4 linked D-mannuronic acid
and variable proportions of its 5-epimer
L-guluronic acid
GDP-mannuronic acid The alginate operon (algD,
alg8, alg44, algK, algE,
algG,algX, algL, algI, algJ,
algF, and algA) and algC
Negatively
charged
Hay et al., 2010; Moradali
et al., 2015
eDNA Nucleic acid − Cell lysis Negatively
charged
Allesen-Holm et al., 2006;
Ma et al., 2009
Type 4* pili Multiprotein complex/
Type 4a pili
− The pilM/N/O/P/Q and
the fimU-pilVWXY1Y2E
operons
− Ayers et al., 2009; Burrows,
2012
Flagella* Multiprotein complex − At least 41 genes
clustered in three regions
of the genome encode
flagellin structural and
regulatory components
− Jyot and Ramphal, 2008
* Are not commonly considered as classical matrix molecules of biofilm, but important for biofilm maturation.
di-GMP in P. aeruginosa which controls cellular level of this
molecule in response to perceived stimuli (Ryan et al., 2006).
The second group is represented by cyclic di-GMP sensing
proteins which also act directly as effectors or via protein-protein
interactions to mediate the output response (Römling et al.,
2013). For example, cyclic di-GMP is essential for the activation
of alginate polysaccharide polymerization (Remminghorst and
Rehm, 2006). Experimental evidence indicated that a pool of
cyclic di-GMP is synthesized by MucR (a hybrid GGDEF/EAL
domain-containing protein) in the proximity of the alginate
biosynthesis/secretion multi-protein complex of P. aeruginosa
(Hay et al., 2009b; Wang et al., 2015). Cyclic di-GMP binds to
PilZ domain of Alg44 protein and allosterically activates alginate
polymerization via interaction with Alg8 glycosyltransferase
(Hay et al., 2009b; Moradali et al., 2015; Wang et al., 2015).
Also, cyclic di-GMP binding to FleQ, a transcriptional master
regulator represses flagella biosynthesis while it concomitantly
derepresses the expression of pel and psl genes (Baraquet et al.,
2012; Figure 2). Likewise, there are many other receptor/effector
proteins which enhance required pathways for biofilm formation
upon cyclic di-GMP binding while they inhibit motility and other
virulence factor synthesis pathways.
In addition, the Wsp chemosensory system in P. aeruginosa
is homologous to chemotaxis signaling pathways which regulate
cyclic di-GMP synthesis via signal transduction (Figure 2). A
cascade of phosphorylations is triggered upon surface attachment
and possibly sensing mechanical stress or other environmental
stimuli which then activate the cyclic di-GMP synthesizing
protein WspR promoting biofilm formation (Hickman et al.,
2005; Porter et al., 2011).
Furthermore, transduction of phosphorylation events via
two-component regulatory systems controls biofilm formation
in a stage-specific manner (Figure 2). This network consists
of BfiRS, BfmRS, and MifRS and GacS/GacA regulatory
components (Petrova and Sauer, 2009). The GacS/GacA
two-component system is part of the global regulatory
pathway comprising LadS/RetS/GacS/GacA/RsmA proteins
(Figure 2). This pathway controls many physiological
responses at post-transcriptional level and is involved in
both motility-sessility and acute-chronic infection transitions.
Of this regulatory pathway, the RNA-binding protein RsmA
negatively controls biofilm formation pathways while it
induces production of T3SS, type 4 pili and other virulence
factors. RsmA binds to psl mRNA and inhibits the translation
of required proteins for Psl polysaccharide biosynthesis
(Irie et al., 2010; Jimenez et al., 2012). It also represses
production of GGDEF/EAL encoding proteins; hence, it inhibits
elevation of cyclic di-GMP levels. In P. aeruginosa, under
stress conditions, this pathway generates non-coding RNAs
(ncRNAs) known as RsmY and RsmZ which counteract RsmA
translational repression activity, consequently derepressing
biofilm formation mainly via cyclic di-GMP level increase
resulting in exopolysaccharides production (Jimenez et al.,
2012).
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FIGURE 2 | Regulatory networks underlying biofilm formation by P. aeruginosa. (A) Elevation of the cyclic di-GMP molecule is a key determinant for the
motility-sessility switch. Environmental cues are sensed by various proteins localized in the envelope of the cells where these proteins contribute to two-component
systems (brown/green rectangles), chemoreceptor-like system (orange complex) and other receptor mediated signaling pathways (arranged in the left side of figure).
Either triggered as phosphorylation cascades (small red circle) or protein-protein interactions, the signals induce diguanylate cyclases (containing GGDEF motif) (red
rectangles) to synthesize cyclic di-GMP from two molecules of GTP (guanosine-5′-triphosphate). Consequently, cyclic di-GMP sensing proteins act as
receptor/effector for specific outputs such as induction of alginate and Pel polymerization, inhibition of motility and derepression of psl/pel expression via FleQ,
induction of attachment and biofilm formation/maturation triggered by two component systems. The two-component systems are interconnected and the
LadS/RetS/GacS/GacA/RsmA regulatory network (green rectangles) plays a key role in the phenotypic switch from motility to sessility and downregulation of QS and
virulence factor production. (B) Various stages of biofilm formation and development were represented. Plus and minus signs represent positive and negative effect of
transcriptional regulators, respectively. CM, cytoplasmic membrane; OM, outer membrane.
There are other regulatory pathways known to be involved in
cyclic di-GMP turnover in response to external stimuli, but the
further precise function still remains to be elucidated (Figure 2).
The Role of QS in Biofilm Development and
Maturation
In addition to abovementioned regulatory networks, biofilm
residents utilize QS systems for cell-to-cell communication
and spatio-temporal regulation of expression of specific genes.
During chronic infection, a major proportion of the colonizing
population was thought to lose QS due to hypermutation events
and phenotypic alterations. However, further investigations have
now revealed that genes involved in the progress of biofilm
maturation and persistence are positively regulated by QS in
P. aeruginosa. Indeed QS-deficient mutants of P. aeruginosa
(i.e., 1lasR1rhlR and 1lasI1rhlI) formed thin and much less
developed biofilms which were more sensitive to antibiotic
treatments and eradication (Shih and Huang, 2002; Nelson et al.,
2009). Furthermore, Bjarnsholt et al. (2010) demonstrated that
at least a part of QS pathways i.e., rhl encoded system and the
production of C4-HSL signals was retained in predominantly
mucoid population at the end of chronic stages coinciding with
overproduction of alginate and rhamnolipids (Bjarnsholt et al.,
2010). The biosurfactants, rhamnolipids, have been suggested to
play an active role in maintenance of the biofilm architecture
by contributing to the formation of internal cavities within the
mature biofilm, allowing proper flow of water and nutrients
(Davey et al., 2003; Boles et al., 2005; Dusane et al., 2010;
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Chrzanowski et al., 2012). Additionally, the production of
pel polysaccharide, eDNA and QS-controlled production of
pyocyanin are critical for biofilm maturation. Pel cross-links
eDNA in the biofilm stalk via ionic interactions and it serves
as important structural components of the biofilm matrix of
P. aeruginosa (Jennings et al., 2015). Furthermore, pyocyanin
molecules can promote eDNA release by inducing bacterial
cell lysis. Pyocyanin binds to eDNA increasing its solution
viscosity which influences the physicochemical interactions of
the biofilm matrix with environment as well as facilitates cellular
aggregations (Das et al., 2013, 2015). Collectively, such molecular
and cellular interactions in combination with other polymeric
substances lead to establishment of a robust and mature biofilm.
ANTIBIOTIC RESISTANCE MECHANISMS
Indeed, the emergence of antibiotic resistant bacteria is a
global health issue. Among identified notoriously multi-drug
resistant (MDR) bacteria, P. aeruginosa has been introduced
as a major concern with a growing threat to global health
resulting in dramatically increasing prevalence of nosocomial
and chronic infections. This is due to the extraordinary capacity
of these bacteria to develop resistance against a wide range of
antimicrobials through various molecular mechanisms which are
often simultaneously present in clinical isolates. Although each
resistance mechanism is related to a specific class of antibiotics,
multiple mechanisms mediate variably resistance to each class of
antibiotics (Potron et al., 2015). Furthermore, the contribution of
each mechanism varies from country to country. Loss or reduced
copy numbers of OprD and overproduction of active eﬄux
pumps, AmpC β-lactamase and extended-spectrum β-lactamases
have been mainly reported as main contributors to multi-drug
resistance phenotypes of P. aeruginosa isolates.
Recent reviews have described the prevalence and
contribution of each resistance mechanism to each class of
antibiotics in detail (Lister et al., 2009; Strateva and Yordanov,
2009; Sun et al., 2014; Hong et al., 2015; Potron et al., 2015).
Here, we reviewed the most frequent and well-understood
findings which are classified into intrinsic, acquired and adaptive
mechanisms, and we provide an update on our understanding of
how P. aeruginosa can survive antibiotic treatments.
Intrinsic Resistance Mechanisms
Like many Gram-negative bacteria, P. aeruginosa can be
intrinsically resistant to particular antibiotics. Such intrinsic
resistance mechanisms stem from the existence of genes in
bacterial genome encoding inherent properties of cell structures
and composition providing protection against toxic molecules
and antimicrobials. It can also be contributed by the lack of
susceptible sites which naturally exist in antibiotic sensitive
species (e.g., resistance to triclosan) (Lambert et al., 2011; Blair
et al., 2015; Figure 3).
However, hydrophilic antibiotics can enter cells by diffusing
through membrane channels or porin proteins in a non-specific
manner. As one of the intrinsic mechanisms, P. aeruginosa
limits antibiotic entry by reducing the number of non-specific
porin proteins and replacing them with specific or more-
selective channels for taking up required nutrients resulting in
lowered permeability to toxic chemicals (Tamber and Hancock,
2003; Figure 3). P. aeruginosa resistance to currently used
broad-spectrum drugs such as carbapenems and cephalosporins
is commonly caused by this adaptation (El Amin et al.,
2005; Baumgart et al., 2010). Many of the clinical strains of
P. aeruginosa displaying resistance to carbapenems such as
imipenem are deficient in the OprD porin which specifically
facilitates the diffusion of basic amino acids, small peptides as
well as carbapenems into the cell (Trias and Nikaido, 1990;
Strateva and Yordanov, 2009).
Active multidrug eﬄux pumps greatly contribute to antibiotic
resistance observed in P. aeruginosa. The involved genes are
ubiquitous in Gram-negative bacteria and they are located
on the genome or plasmids. The multidrug eﬄux pumps
are multi-protein complexes spanning the envelope of Gram-
negative bacteria. They are responsible for expelling various
toxic materials and a wide range of antimicrobials. Because of
their broad substrate specificities they display resistance against
different classes of antibiotics which are chemically unrelated
(Blair et al., 2015; Venter et al., 2015).
P. aeruginosa possesses four well known active multidrug
eﬄux pumps including MexAB-OprM, MexXY/OprM(OprA),
MexCD-OprJ, and MexEF-OprN (Figure 3). The gene sets
encoding these systems are under different regulatory factors;
therefore, the expression levels of these systems significantly
differ under various conditions. The MexAB-OprM and
MexXY/OprM(OprA) are the most clinically important sets
due to their large prevalence in clinical strains and significant
contribution to a wide range of antibiotics (Avrain et al.,
2013). The mexAB-oprM genes show a stable and constitutive
expression in the cell guaranteeing a protective basal level
production of the MexAB-OprM system to consistently expel a
wide range of toxic molecules and antibiotics (Li et al., 2015).
Hence it mainly contributes to natural resistance to antibiotics.
The mexXY-(oprA) genes show lower basal expression levels and
are mainly induced in response to protein synthesis inhibitors
that target the ribosomal machinery (Matsuo et al., 2004; Hay T.
et al., 2013). Both mexCD-oprJ and mexEF-oprN genes are not
typically expressed in wild-type strains or their expression is very
low and they have been proposed not to contribute significantly
to natural antibiotic resistance (Llanes et al., 2011; Li et al., 2015).
There are other forms of multidrug eﬄux pumps such as
MexJK, MexGHI-OpmD, MexVW, MexPQ-OpmE, MexMN,
and TriABC. They are not expressed in wild-type strains but
may contribute to adaptive resistance against antibiotic or biocide
agents when expressed in resistant strains (Lister et al., 2009;
Avrain et al., 2013).
On the other hand, they might play role in other physiological
pathways as well. For example, The MexEF-OprN and MexGHI-
OpmD sets can modulate QS systems by exporting the quinolone
signaling molecule PQS reducing its cellular concentration
resulting in the reduction of virulence factor production, which
is presumably in favor of establishment of chronic infections
(Köhler et al., 2001; Aendekerk et al., 2005; Lamarche and
Déziel, 2011). However, many of these mechanisms remain still
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FIGURE 3 | Intrinsic, acquired and adaptive mechanisms confer antibiotic resistance in P. aeruginosa. For each mechanism, various molecular strategies,
which confer resistance to specific class of antipseudomonal antibiotics (Car., Carbapenems; Ceph., Cephalosporins; Pen., Penicillins; Ami., Aminoglycosides; Flu.,
Fluoroquinolones; Mac., Macrolides and Pol., Polymyxins), were presented at the top of the figure (underlined) Intrinsic mechanisms such as structural barriers [e.g.,
EPS (extracellular polymeric substances)], OprD reduction and basal production of AmpC β-lactamase and MexAB/XY efflux pumps confer a basal resistance to some
group of antibiotics. However, in acquired resistance, mutational changes in the oprD gene, transcriptional repressors causingupregulation of resistance genes and
efflux pumps conferring resistance against a wider spectrum of antibiotics. Plasmid-mediated resistance is very potent as a variety of resistance genes can be
exchanged among bacteria. Either mediated by mutational changes in the genome or in plasmids, resistance to polymyxins occurs via modification of LPS
(lipopolysaccharide) components hindering binding of the antibiotic to this layer. Adaptive resistance occurs in the presence of antibiotics mainly via mutation in
regulatory genes. This is a transient and reversible resistance, which will reverse upon removal of antibiotics. Stars represent antibiotics and dashed/wavy lines
represent transcriptional levels of each gene product. CM, cytoplasmic membrane; OM, outer membrane.
unclear with regard to their connection with other physiological
pathways and their clinical relevance.
Another player of intrinsic resistance and basal lower level
antibiotic susceptibility in P. aeruginosa is the gene encoding
an inducible β-lactamase (AmpC) (Figure 3). Particularly,
chromosomal expression and production of AmpC confers low
level resistance to aminopenicillins and most cephalosporins
because these antibiotics strongly induce the production of
AmpC which consequently hydrolyzes these substrates (Oliver
et al., 2015). However, through adaptive or acquired resistance
mechanisms AmpC can be overproduced, consequently
conferring resistance to a wider range of antibiotics such as
aminoglycosides and fluoroquinolones (Umadevi et al., 2011).
These mechanisms will be further discussed later.
Acquired Resistance Mechanisms
P. aeruginosa can acquire resistance to antibiotics through
mutation of intrinsic genes or horizontal acquisition from
other bacteria through transferring plasmids carrying genetic
materials encoding for antibiotic resistance (Davies, 1997; Davies
and Davies, 2010). Contrary to intrinsic mechanisms, acquired
resistance is related to antibiotic selection and this selective
advantage occurs in the presence of antibiotic compounds
leading to irreversible resistant population (Lee et al., 2016).
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Therefore, similar to intrinsic resistance, acquired resistance is
stable too and it can be transmitted to progeny.
However, due to over-expression of resistance genes and
transmissibility by plasmids, acquired resistance is a potent
mechanism which confers resistance to a wide spectrum of
antibiotics as well as leads to increased prevalence among clinical
and environmental strains.
Boosted Antibiotic Resistance via
Mutations
Intrinsic resistance genes are negatively or positively regulated
by one or more regulatory mechanisms which confer a basal
lower susceptibility of P. aeruginosa to a narrow spectrum of
antibiotics. However, mutation in regulatory pathway could
increase promoter activities resulting in unleashing gene
expression and overproduction of protein products such as
AmpC and multi-drug eﬄux pumps systems. Consequently, it
causes higher level of resistance to antibiotics (Blair et al., 2015;
Figure 3).
As a common mutational feature of P. aeruginosa isolates,
resistant clinical mutants display a constitutive high level of
AmpC production even in the absence of antibiotic inducers.
This is mainly due to mutational inactivation of ampD (repressor
of ampC) and specific point mutations of ampR, both encoding
two regulatory proteins important in induction of the ampC
gene (Juan et al., 2005; Figure 3). Consequently, it turns into a
major cause of greater resistance to a wide range of antibiotics
such as most of the β-lactams (e.g., ticarcillin and piperacillin)
as well as monobactams, third-generation and fourth-generation
cephalosporins (Lister et al., 2009; Berrazeg et al., 2015). One
study showed that 73% of tested clinical strains showed AmpC
overproduction (Henrichfreise et al., 2007).
Several regulatory loci such as mexR, nalD, nalB, and
nalC negatively control the expression of the mexAB-oprM
operon in P. aeruginosa. On the other hand, various loss-of-
function mutations in these loci derepress the expression of the
mexAB-oprM operon leading to the overproduction of MexAB-
OprM complex conferring a greater resistance to carbapenem
antibiotics (Quale et al., 2006; Lister et al., 2009; Kao et al.,
2016; Figure 3). Likewise, overproduction of other multidrug
eﬄux pumps such as MexXY and MexCD-OprJ can occur
via mutations in regulatory loci leading to unleashing gene
expression and a greater resistance to a variety of antimicrobial
agents (Lister et al., 2009; Figure 3).
Another clinically important and prevalent mutational
alteration is attributed to OprD porin channel. This porin
channel is localized in the outer membrane of P. aeruginosa
and it is characterized as a carbapenem-specific porin (Figure 3).
Therefore, loss or reduction of OprD can reduce permeability
of the outer membrane to carbapenems (Epp et al., 2001;
Gutiérrez et al., 2007; Kao et al., 2016). The emergence of
resistance to imipenem and reduced susceptibility to meropenem
has been reported upon the occurrence of oprD mutations.
Genetic alteration in oprD can occur via nucleotide insertion
or deletion and point mutations resulting in frameshift of the
gene sequence, amino acid substitution, shortened putative loop
L7 and premature stop codons (Kao et al., 2016). Furthermore,
downregulation of oprD expression can be mediated by other
regulatory factors such as MexT which itself concurrently
upregulates mexEF-oprN expression (Köhler et al., 1997; Ochs
et al., 1999).
Additionally, fluoroquinolone resistance among P. aeruginosa
isolates can be mediated by either mutational changes within the
fluoroquinolone targets i.e., DNA gyrase (gyrA and gyrB) and/or
topoisomerase IV (parC and parE) or overproduction of active
or inducible eﬄux pumps (Lee et al., 2005; Sun et al., 2014;
Figure 3).
Plasmid-Mediated Resistance
Bacterial plasmids serve a central role as a potent vehicle for
acquiring resistance genes and subsequent delivery to recipient
host. This is so-called horizontal gene transfer whereby genetic
elements can be transferred between bacterial cells particularly
via conjugation. Some resistance plasmids are broad host range
which can be transferred among various species via bacterial
conjugation, while narrow host range plasmids are transferred
among a small number of cells from similar bacterial species.
For example, plasmid RP1 can transfer resistance genes to most
Gram-negative bacteria (Kenward et al., 1978).
Plasmid-encoded antibiotic resistance confers resistance
to different classes of antibiotics that are currently applied
in frontline of clinical treatments such as β-lactams,
fluoroquinolones and aminoglycosides (Bennett, 2008; Figure 3).
So far, P. aeruginosa resistance via horizontal gene transfer has
been reported for the genes encoding β-lactam-hydrolyzing
enzymes known as the extended-spectrum β-lactamases and the
carbapenemases, aminoglycoside-modifying enzymes, 16S rRNA
methylases resulting in high-level pan-aminoglycoside resistance
(Poole, 2011).
The genes encoding extended-spectrum β-lactamases and
carbapenemase are clinically important not only due to their
hydrolyzing activity on a wide range of β-lactams such as
carbapenems and extended-spectrum cephalosporins, but also
for their worldwide prevalence (Paterson and Bonomo, 2005;
Blair et al., 2015; Sullivan et al., 2016). The global epidemiology
of carbapenem-resistant P. aeruginosa was recently analyzed
by Hong et al (Hong et al., 2015). They reported that the
geographical prevalence of these genes differs from country
to country, whereas the genes encoding carbapenemases such
as IMP, VIM, and NDM type metallo-β-lactamases have been
found in all continents (Johnson and Woodford, 2013; Meletis
and Bagkeri, 2013; Hong et al., 2015). Almost all types of
transferable carbapenemases, except SIM-1, have been detected
in P. aeruginosa, and the prevalence of carbapenem-resistant
isolates of P. aeruginosa is gradually increasing (Meletis and
Bagkeri, 2013; Hong et al., 2015).
It is of concern that transferable plasmids carrying some
of the resistance genes are mobile among a wide range
of unrelated Gram-negative bacteria which increases the
antimicrobial resistance transfer rate causing increasing
treatment complications (Hong et al., 2015). Recent findings
about antibiotic resistance have been even more concerning
and warning. Liu et al. reported the first evidence of
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plasmid-mediated colistin resistance from China (Liu et al.,
2016; Figure 3). Colistin (or polymyxin E) belongs to the family
of polymyxins. The members of this class of antibiotics such as
polymyxin B and colistin have been the last resort for antibiotic
treatment of carbapenem-resistant bacteria such as P. aeruginosa
isolates and Enterobacteriaceae (Falagas and Kasiakou, 2005).
Resistance to polymyxins was previously reported to occur
via chromosomal mutations (Moskowitz et al., 2012; Gutu
et al., 2013), however, new evidence suggests plasmid-mediated
resistance through the mobilization of the mcr-1 gene which
consequently confers resistance to colistin (Figure 3). This gene
was discovered in E. coli strain SHP45 collected from agricultural
products. It is more concerning that the plasmid carrying
mcr-1 was mobilized into K. pneumoniae and P. aeruginosa via
conjugation (Liu et al., 2016). This finding has triggered serious
concerns about the emergence of pan-drug-resistant Gram-
negative bacteria leading to almost untreatable infections. Recent
findings provided some evidence of the spreading high-risk of
clone ST654 of P. aeruginosa containing the genomic blaNDM−1
resistance gene which also conferred resistance to colistin. It is
likely that blaNDM−1 was acquired via genetic exchange between
P. aeruginosa and K. pneumoniae isolate in the same patient
(Mataseje et al., 2016).
Adaptive Resistance Mechanisms
Compared to other types of resistance mechanisms, adaptive
mechanisms are not really well understood. Adaptive resistance
is an unstable and transient form of resistance, which is
induced in the presence of specific antibiotics and other
environmental stresses. This type of resistance mainly relies on
induced alterations in gene expression and protein production or
alterations in antibiotic targets and it is reversal upon removal of
external stimuli leading to re-gaining susceptibility (Barclay et al.,
1992; Xiong et al., 1996; Fernández et al., 2011). This mechanism
has been seen mediating the resistance of P. aeruginosa isolates
to β-lactams, aminoglycosides, polymyxins and fluoroquinolones
(Zhang et al., 2001; Poole, 2005; Fernández et al., 2010; Khaledi
et al., 2016).
It has been seen that once strains encounters certain
concentrations of antibiotics, they can tolerate higher
concentrations in subsequent exposures, while cross-resistance
to other antibiotics may occur as well (Mouneimné et al., 1999;
Fujimura et al., 2009; Fernández et al., 2011; Pagedar et al., 2011).
Furthermore, these alterations may link to other physiological
events triggered by other stimuli and stresses as well as mutations
in some specific genes (Xiong et al., 1996; Karlowsky et al., 1997;
Fernández et al., 2011).
Using isolates from CF patients, it was shown that adaptive
resistance of P. aeruginosa to fluoroquinolones such as
ciprofloxacin is due to multiple mutations in the known-
resistance genes including the gyrA, gyrB, nfxB, and orfN which
were concomitant with mutations in the genes involved in cyclic
di-GMP signaling (Figure 3). Mutations of nfxB were prevalent
leading to loss of function of NfxB transcriptional repressor
and consequently leading to the overproduction of MexCD-OprJ
eﬄux pump (Wong et al., 2012; Figure 3). This eﬄux pump
is an important determinant of resistance to fluoroquinolone
antibiotics (Hirai et al., 1987). On the other hand, another study
showed that expression of the mexCD-oprJ genes depends on
the sigma factor AlgU and leads to resistance to the biocide
chlorhexidine (Fraud et al., 2008). AlgU is well-known stress
response sigma factor which positively regulates overproduction
of alginate in mucoid isolates (Hershberger et al., 1995).
Another group showed that P. aeruginosa can acquire and lose
resistance in the presence and absence of colistin, respectively.
This occurred via adaptive multiple mutational mechanisms and
genetic reversion (Lee et al., 2016). It was also demonstrated
that resistance to certain polycationic antimicrobials such as
aminoglycosides, polymyxins and cationic antimicrobial peptides
can be mediated by altering the lipid A structure in LPS. This was
caused bymultiple mutations in cognate regulatory proteins such
as the two-component systems PhoP-PhoQ, PmrA-PmrB, CprR-
CprS, and ParR-ParS (Barrow and Kwon, 2009; Fernández et al.,
2012; Figure 3). Other studies showed that further and complex
genetic alterations affecting regulatory pathways including those
causing amino acid substitutions in these cognate regulatory
proteins such as PhoQ and PmrB are involved in polymyxin
resistance. This is why the mechanism of resistance of P.
aeruginosa to colistin was found to vary among isolates (Lee et al.,
2016). Interestingly, this study showed that the acquisition of
colistin resistance via many amino acid substitutions is reversible
in colistin-susceptible revertants. However, even in the absence of
colistin, resistance was preserved for some time and emergence of
revertants may not occur so fast (Lee et al., 2016).
QS-Dependent Antibiotic Resistance
Some direct and indirect evidences have been found linking
the QS systems with antibiotic resistance mechanisms in P.
aeruginosa (Rasamiravaka and El Jaziri, 2016), but further
exploration is needed for better understanding. Using clinical
strains of P. aeruginosa, it was shown that the las system
positively links to the expression of mexY gene encoding the
inner-membrane drug/H+ antiporter protein MexY (Pourmand
et al., 2015) which is a key subunit of the MexXY-oprM complex
known as a major determinant of aminoglycoside resistance
(Lau et al., 2014). On the other hand, some studies showed
that CF-infecting strains with the common lasR loss-of-function
mutations were more resistant to therapeutic antibiotics such
as tobramycin, ciprofloxacin and ceftazidime. The reported
antibiotic resistances in the lasR mutants were attributed to
increased β-lactamase activity, bacterial metabolic adaptation or
metabolic shifts (D’Argenio et al., 2007; Hoffman et al., 2010).
However, the relationship of antibiotics susceptibility with the rhl
encoded QS system and production of C4-HSL signals remains
unclear (Bjarnsholt et al., 2010). Some supporting evidence was
obtained by, treating P. aeruginosa biofilms with ciprofloxacin
which upregulated the production and secretion of the virulent
factor LasB, which is under the control of Rhl QS system (Oldak
and Trafny, 2005; Figure 1).
Furthermore, two independent studies reported that the
clinical strains of P. aeruginosa with QS-deficient phenotypes
and negative for the production of QS-dependent virulence
factors could cause infections and tend to be less susceptible
to antimicrobial agents (Karatuna and Yagci, 2010; Wang
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H. et al., 2013). However, it was not shown how these
mechanisms might link to each other while many of these
clinical strains could also form biofilms with antibiotic resistance
traits and many regulatory pathways for biofilm development
are under the control of QS systems. Zhao et al. reported
some supporting information showing the importance of QS
systems in both biofilm formation and antimicrobials induced
expression of ampC (Zhao et al., 2015). Earlier studies showed
that by overexpressing the chromosomal type 1 β-lactamase,
QS-dependent virulence factors were reduced and strains were
less virulent (Ramisse et al., 2000). Also, Kong et al. analyzed
the dual role of the AmpR transcriptional regulator where
it positively regulated β-lactamases and negatively regulated
the virulence factors through QS systems (Kong et al.,
2005).
Balasubramanian et al. analyzed co-regulatory and
transcriptional networks of three co-existing mechanisms
involved in β-lactam resistance, alginate production and
modulation of virulence factor expression. They showed
that while AmpR positively and negatively regulates β-
lactamases and QS-dependent proteases, respectively, there is an
intimate crosstalk between the AmpR regulon and the master
regulator AlgU which positively regulates alginate production
(Balasubramanian et al., 2011). This gave more insight into the
complexity of such co-existing networks. Recent findings also
showed that high levels of cyclic di-GMP mediated by the SagS
regulator contributes to elevated antibiotic resistance via BrlR
regulon-dependent upregulation of cognate genes encoding
MexAB-OprM and MexEF-OprN multidrug eﬄux pumps
(Gupta et al., 2014).
The periplasmic TpbA tyrosine phosphatase was also reported
as a regulatory candidate for linking QS signaling and biofilm
formation. This protein was shown to be positively regulated by
the las QS system at transcriptional level. Upon production of
TpbA and its phosphatase activity in the periplasm, the cyclic
di-GMP synthesizing protein TpbB is dephosphorylated at a
tyrosine residue in periplasmic domain leading to inactivation
of TpbB and a reduction in cyclic di-GMP levels and in turn
Pel production, hence inhibiting biofilm development (Ueda and
Wood, 2009). TpbA-dependent cyclic di-GMP reduction was also
linked to increasing eDNA release by cell lysis (Ueda and Wood,
2010).
Overall, the reason for inconclusive information about
the relation of the QS system and antibiotic resistance
mechanisms is based on the fact that there are various layers
of regulatory pathways associated with both QS systems and
antibiotic resistance mechanisms in P. aeruginosa. Therefore,
understanding the interplay between hierarchical QS systems
and various antibiotic resistance mechanisms needs further
exploration.
ADAPTIVE RADIATION FOR PERSISTENCE
Adaptation to the surrounding environments is an extraordinary
capability of P. aeruginosa. It enables P. aeruginosa to inhabit
diverse ecological niches such as colonization of various hosts as
well as long term persisting infections. The adaptation process
is designated as adaptive radiation by which initial clones would
diversify into a variety of genotypes and phenotypes over time
until the most favorable and adapted descendants are selected for
long term persistence (Hogardt and Heesemann, 2010). A typical
example is adaptation of P. aeruginosa isolates to the CF airways.
Various studies have shown that initial colonization of CF lungs
is caused by wild-type strains existing in the environment.
For bacteria, the CF lungs encompass various stresses such
as oxidative stresses and immune responses and inter-species
competition followed by antibiotic treatment. Therefore, initial
clones undergo substantial adaptation processes to survive such
hostile environments.
Here, adaptive radiation is mainly due to intense genetic
adaptations leading to the thousands of generations displaying
diverse genotypes and phenotypes that emerge in vivo, while
subjected to selection pressure imposed by the CF lung
milieu (Figure 4). Therefore, selected variants display different
genotypes when compared with initial wild-type colonizers and
persist in the CF lungs leading to clonal expansion within
patients and establishment of chronic infections (Mathee et al.,
1999; Kong et al., 2005; Boles and Singh, 2008; Driffield et al.,
2008; Workentine et al., 2013). By assessing a wide selection of
phenotypes,Workentine et al. showed that the overall population
structure in one chronically infected patient can be much more
heterogeneous in phenotypes than what has been previously
documented (Workentine et al., 2013). Furthermore, it has been
reported that transmission of strains from patient to patient can
result in the coexistence of highly divergent bacterial lineages
(Winstanley et al., 2016).
Generally, phenotypic adaptation of these strains include slow
growth, auxotrophy, virulence deficiency via downregulation
of QS systems, loss of motility, biofilm formation, alginate
overproduction and mucoid phenotype, antibiotic resistance,
hypermutability, and lipopolysaccharide modifications.
Downregulation of virulence factors such as flagella motility,
T2SS/T3SS apparatus, and toxic components results in less
inflammatory and phagocytic responses since the pathogen is
less detectable for the immune system (Mahenthiralingam et al.,
1994; Hogardt and Heesemann, 2010). Analysis of many clinical
isolates showed these alterations represent convergent molecular
evolution among many clinical isolates and mutation of 52 genes
are mainly responsible for substantial phenotypic alterations
associated with virulence traits and resistance (Diaz Caballero
et al., 2015;Marvig et al., 2015). Of these genes, common adaptive
mutations occur in regulatory genes including lasR, pvdS, rpoN,
mucA, mexT, nfxB, mexR, nalD, retS, and ampR (Figure 4).
Collectively, this leads to remodeling regulatory networks and
developing a general adaptation pattern as explained below
(Higgins et al., 2003; Hogardt and Heesemann, 2010; Rau et al.,
2010; Winstanley et al., 2016).
Mutation of lasR, pvdS, and rpoN impairs central QS
system signal processing leading to the deficiency in virulence
traits. In wild-type strains, the LasR and PvdS regulators
control the expression of a large number of genes including
key virulence factors (Table 1, Figure 4) and pyoverdine for
iron acquisition, respectively (Table 1; Hoffman et al., 2009;
Imperi et al., 2010; Jiricny et al., 2014; LaFayette et al.,
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FIGURE 4 | Remodeling of regulatory networks in P. aeruginosa during adaptive radiation and transition from acute to chronic infections. (A) During
pathogenesis, adaptation to the CF lung environment occurs through “adaptive radiation” where intense genetic mutations lead to diverse genotypes and phenotypes
(colorful ellipsoids) within bacterial populations followed by the selection of colonizers. Mutational adaptation and selection of generations drive bacterial transition from
acute to chronic traits. (B) Remodeling of key regulatory networks between acute and chronic infections occurs mainly via mutational adaptation in cognate genes.
Mutated lasR, ampR, and retS genes are key determinants in this process by which QS, virulence factor production and motility are downregulated, while synthesis of
cyclic di-GMP, exopolysaccharides and various multidrug efflux pumps are upregulated. Mutation of mucA results in a defect in MucA (anti-sigma factor) releasing
AlgU (positive regulator of alginate operon) that induces overproduction of alginate and the mucoid phenotype. Of important acute traits are flagellum, type 4 pili,
T1SS, T2SS, T3SS (types 1 to 3 secretion systems), ExoT (exotoxins), Lip (lipases), AprA (alkaline proteases). The type 6 secretion system (biofilm-associated and
toxin-delivering device to other bacteria) and efflux pumps and the production of EPS are part of chronic traits which confer antibiotic resistance and/or mediate
biofilm formation. Plus and minus signs represent positive and negative effect of transcriptional regulators, respectively. Red cross indicates mutagenesis. CM,
cytoplasmic membrane; OM, outer membrane.
2015). The alternative sigma factor RpoN has been also
found to regulate many cell functions such as motility and
virulence factors production via QS system (Cai et al., 2015;
Figure 4). Additionally, knocking out mutation of mucA locus
encoding anti-sigma factor MucA results in releasing the RNA
polymerase sigma factor σ22 (AlgU) which itself positively
regulates expression of the alginate biosynthesis operon and
stress response mechanisms while it negatively regulates several
virulence factors such as flagella, pili, T3SS, and Rhl quorum
sensing signals (Folkesson et al., 2012). Development of the
mucoid phenotype mediated by alginate overproduction as well
as the formation of highly structured biofilms is the hallmark
of chronic infections (Schurr et al., 1996; Hay I. D. et al., 2013;
Figure 4).
Another common mutation has been reported in the mexT
locus resulting in activation of MexT, the positive regulator
of MexEF-OprN eﬄux pump, which in turn led to antibiotic
resistance. In addition, the induction of MexEF-oprN production
is linked to extruding QS signaling molecules and reduction of
virulence factor production (Tian et al., 2009; Figure 4). The
MexEF-OprN production is undetectable in wild-type strains
due to the non-functionality of the mexT gene (Maseda et al.,
2000, 2010). Furthermore, mutations of repressor genes nfxB
and mexR/nalD in clinical strains upregulated the production of
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the MexCD-OprJ and MexAB-OprM eﬄux pumps, respectively,
conferring resistance to a wider range of antibiotics (Higgins
et al., 2003; Sobel et al., 2005; Jeannot et al., 2008; Rau et al.,
2010; Figure 4). Also, mutation of other genes such as gyrA/gyrB
(DNA gyrase), mexZ (transcriptional regulator of the mexXY)
andmexS (transcriptional regulator of themexEF) are commonly
attributed to antibiotic resistance during mutational adaptations
(Marvig et al., 2015; Figure 4).
As part of RetS/GacS/GacA/RsmA regulatory pathway,
the retS gene is important for phenotypic shifting from
acute to chronic infections (Lapouge et al., 2008; Moscoso
et al., 2011). The retS mutation repressed the production of
virulence factors such as T3SS and swarming motility while it
upregulated production of the T6SS (type 6 secretion system)
and exopolysaccharides Pel/Psl required for biofilm formation
(Moscoso et al., 2011; Figure 4). The T6SS is a puncturing
device for delivery of proteins and toxins into the competing
bacteria and the host cells and an important survival advantage
for P. aeruginosa. It is also required for biofilm formation while
being considered as a virulence factor (Chen et al., 2015). This
transitional impact was shown to be mediated by high levels of
cyclic di-GMP (Boehm et al., 2010; Paul et al., 2010; Moscoso
et al., 2011).
Mutation of the ampR gene is another common mutational
adaptation with a large impact on remodeling of physiological
traits (Figure 4). The AmpR global regulator in P. aeruginosa
regulates not only resistance to different classes of clinically
relevant antibiotics, but also expression of hundreds of genes
involved in diverse physiological processes such as virulence, QS
systems and stress responses (Balasubramanian et al., 2015). It is
understood that the ampRmutation induces adaptations leading
to chronic infection including the downregulation of stress
responses and virulence factors via downregulating QS systems,
and boosting biofilm formation and alginate overproduction
by causing elevation of cyclic di-GMP levels. Additionally,
it induced AlgU activity, and resistance to fluoroquinolone
through activation of MexT upregulating the MexEF-OprN
eﬄux pump as well as increasing twitching motility and T6SS
production (Balasubramanian et al., 2011, 2012, 2014, 2015;
Figure 4).
Other adaptive mutations of CF isolates have been commonly
reported in anti-mutator genes including mutS, mutT, mutL,
mutY, mutM, and uvrD conferring a “hypermutability
phenotype” with elevated mutation rates due to the lack
of DNA repair mechanisms. This phenotype has been
described as being caused by later mutational events as
they are understood to occur after mutation of the lasR and
mucA genes known as earlier mutations. However, other
reports postulated that mutation of anti-mutator loci may
increase the rate of other adaptive mutations (Oliver and Mena,
2010).
Hypermutators are very prevalent in CF isolates and they
are shown to have correlation with higher antibiotic resistance
particularly in the late stage of chronic infections. However,
hypermutators also display other phenotypes such as mucoidity,
lack of motility and LPS production (Oliver et al., 2000; Ciofu
et al., 2010; Varga et al., 2015).
Other distinct phenotypes correlated with adaptation to CF
airways are the small-colony variants (SCVs). They are associated
with prolonged persistence and chronic infections in CF lungs
and obstructive pulmonary diseases (Malone, 2015). They have
been characterized as variants forming rugose small colonies
on solid media (1–3 mm in diameter) with slow growing,
autoaggregative and enhanced biofilm formation characteristics
combined with enhanced surface attachment and hyperpiliation
for twitching (Häussler et al., 1999, 2003; Kirisits et al., 2005).
In vitro analyses showed that the SCVs display increased
resistance to a wide range of antibiotics (Wei et al., 2011).
Different studies have demonstrated that the presence of SCVs
in the CF lung is associated with poorer lung function and
clinical outcomes (Häussler et al., 1999, 2003; Schneider et al.,
2008).
It has been understood that SCVs show high levels of cyclic
di-GMP production aligned with increased production of Pel and
Psl exopolysaccharides (Starkey et al., 2009). So far investigations
regarding themolecularmechanisms underlying SCVs formation
confirmed loss-of-function mutations in regulatory genes such as
wspF, yfiR and rsmA and some other genes which alter regulatory
networks in favor of enhanced cyclic di-GMP production (Irie
et al., 2010; Malone et al., 2012; Blanka et al., 2015; Malone, 2015).
On the other hand, an upregulating cyclic di-GMP synthesis
pathway is a key determinant of exopolysaccharide production
leading to highly developed biofilms. However, it still remains
unclear how two distinct phenotypes i.e., cell within mucoid
biofilm and SCV differ in regard to the cyclic di-GMP mediated
signaling pathways.
SURVIVAL BY STRINGENT RESPONSE
AND PERSISTER FORMATION
Stringent response to environmental stresses such as nutritional
starvation and response to antibiotics and oxidative stresses share
a similar outcome of adaptation i.e., all are leading to dormancy
and persister formation. In both responses, bacteria slow down
their metabolism through downregulating the expression of
genes participating in the biosynthesis of proteins, ribosomes,
cell wall, nucleic acid metabolism, and virulence factors. These
dramatic metabolic alterations result in arresting cell growth and
cell division in favor of bacterial survival (Eymann et al., 2002;
Hesketh et al., 2007; Durfee et al., 2008).
Persisters are defined as subpopulations of cells, occurring at
very low frequency, which stochastically emerge in the presence
of stress. They show very slow growth enhancing survival under
stress while viability of the majority of the population is severely
impaired. Upon stress removal, persisters turn back to normal
growth to propagate, which coincides with regained sensitivity
to stress. Such persistence was suggested to be based on the
heterogeneity of population by means of epigenetic mechanisms,
not genetic mutations (Fasani and Savageau, 2015).
Various studies have provided evidences showing the link
between stringent response and persistence, but mostly using
E. coli as a model which can be informative for P. aeruginosa
as it possesses homologous signaling pathways (Fung et al.,
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2010; Maisonneuve et al., 2013; Amato et al., 2014; Ramisetty
et al., 2016). There are only a few studies aiming to explain
such responses, but they provided inconclusive explanations.
Therefore, we summarized the general findings in order to
propose the underlying molecular mechanisms in P. aeruginosa.
Molecular Mechanisms Underlying
Stringent Responses and Persisters
Notably, increased levels of (p)ppGpp (collectively designated
for guanosine pentaphosphate and guanosine tetraphosphate)
molecules in the cells is a central triggering alarmone for
both persistence and stringent response (Potrykus and Cashel,
2008; Wu et al., 2010; Amato et al., 2014). The cellular levels
of (p)ppGpp are mediated by the activity of the (p)ppGpp-
synthesizing and degrading enzymes such as RelA and SpoT in
response to external stimuli (Bremer and Dennis, 2008).
In stringent response when E. coli encounters amino
acid deprivation, the ribosome-associated RelA synthesizes
ppGpp molecules to an upper level. In association with the
transcriptional regulator DksA (global regulator of metabolism),
ppGpp interacts with RNA polymerase and inhibits the
transcription of ribosomal RNA promoters. This inhibitory
impact is concomitant with activation and upregulation of
pathways for amino acid biosynthesis and the transcription of
stress response genes (Potrykus and Cashel, 2008; Dalebroux and
Swanson, 2012; Amato et al., 2014). Amato et al. (2013) found
that stringent responses are linked to the emergence of persisters
by involving ppGpp based regulatory events (Amato et al., 2013).
The persister state is typically based on the activity of
genetically encoded toxin-antitoxin (TA) modules particularly
in response to antibiotics, but proposed as being activated by
the same acting elements i.e., RelA or SpoT and (p)ppGpp in
E. coli (Maisonneuve et al., 2013). These TA system are widely
distributed in genomes or plasmids of bacteria and archaea
(Van Melderen, 2010). Basically, the toxin element is a stable
protein while the cognate antitoxin element either is a protein
or a small RNA molecule which are metabolically unstable
under unfavorable conditions. A small RNA antitoxin directly
inhibits the toxin translation by pairing with toxin mRNA or
inactivate toxin by direct binding. A protein antitoxin on the
other hand either degrades toxin mRNA or blocks the activity
of cognate protein toxin via direct protein-protein interaction
or protective interaction with toxin substrates. Impairment of
antitoxin function under certain stresses such as antibiotics
as well as nutritional stresses leads to the accumulation and
activation of toxin proteins. Consequently, the toxin targets and
interferes with key cellular processes such as DNA replication,
and the synthesis of tRNA, membrane components, and ATP
leading to the inhibition of cell growth and cell division to
form a dormant or persister cell (Christensen-Dalsgaard et al.,
2010; Wen et al., 2014). Presumably, bacteria switch off their
active metabolism upon exposure to stress to evade starvation
or antibiotic impact on their cellular targets. Christensen et al.
demonstrated that E. coli encodes at least 10 TA loci and all of
which could be induced by nutritional starvation and antibiotics
(Christensen et al., 2001; Christensen-Dalsgaard et al., 2010).
So far,Maisonneuve et al. (2013) have proposed the best model
presenting the hierarchical molecular mechanisms for E. coli
persistence with the involvement of the key players including
RelA/SpoT enzymes, (p)ppGpp signaling, Lon protease (ATP-
dependent protease), inorganic polyphosphate (PolyP), and
toxin-antitoxins systems (Maisonneuve et al., 2013; Figure 5).
This model explains that (p)ppGpp synthesized by RelA/SpoT
inhibits PolyP degradation, while PolyP accumulation stimulates
Lon protease to degrade the antitoxin leading to the activation
of toxin for arresting cellular processes and growth. Previously,
it was shown in E. coli that in response to nutritional stress
and antibiotics, transcriptional activation of TA loci depended
on protease activity of Lon protease on antitoxin which itself
repressed the TA promoter (Christensen-Dalsgaard et al., 2010).
Furthermore, it was suggested that the complex of Lon protease
with PolyP could promote ribosomal protein degradation for
supplying required amino acids during starvation (Kuroda et al.,
2001; Figure 5).
P. aeruginosa Stringent Response and
Persisters
Required elements of stringent response and persistence
including the ppGpp alarmone, SpoT, RelA, DksA, and the TA
modules have been characterized in P. aeruginosa (Figure 5).
Mutants deficient in relA and/or spoT genes showed increased
sensitivity to heat shock, oxidative and osmotic stresses as well as
antibiotics while becoming less virulent. Stringent response and
RelA/SpoT activity for production of ppGpp were found to be
crucial for regulation of virulence factor production (Erickson
et al., 2004; Viducic et al., 2006; Boes et al., 2008; Nguyen
et al., 2011; Vogt et al., 2011). Also, there is some experimental
support that P. aeruginosa utilizes stringent response to protect
cells from oxidative stresses generated by toxic reactive oxygen
species (ROS) under aerobic conditions. The mutants deficient
in relA and spoT genes were highly susceptible to multiple
oxidants. This study showed that (p)ppGpp signaling is necessary
for optimal expression of catalase and superoxide dismutase
enzymes as major ROS scavengers, but it was assumed to
be indirectly regulated through a complex regulatory network
(Sampathkumar et al., 2016; Figure 5). Because, (p)ppGpp
signaling is also required for full expression of other regulatory
pathways controlling antioxidant response such as the stress
response regulator RpoS as well as both Las and Rhl QS systems
(van Delden et al., 2001; Kohanski et al., 2008; Schafhauser
et al., 2014; Sampathkumar et al., 2016; Figure 5). The proposed
E. coli model for the activation of the TA system via Lon
protease has not been shown for P. aeruginosa, yet. However,
different studies indicated that Lon protease activity was induced
by aminoglycosides and lon mutants were highly susceptible to
ciprofloxacin while lon was also required for biofilm formation,
motility and virulence (Marr et al., 2007; Breidenstein et al.,
2012). Molecular mechanism of these pathways have not been
well characterized, but as proposed previously, interconnection
of various regulatory and signaling pathways for appropriate
responses leading to either as stringent/persistence, biofilm
formation or virulence is anticipated (Kim et al., 1998).
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FIGURE 5 | P. aeruginosa stringent response and persister formation. Stringent response is triggered by particular stresses such as amino acid and fatty acid
starvation, iron/phosphor depletion and oxidative stress [e.g., reactive oxygen species (ROS)]. The (p)ppGpp alarmone is a key determinant for stringent response and
it is elevated by RelA/SpoT enzymes. Generally, (p)ppGpp elevation and the PolyP (inorganic polyphosphate) and Lon protease complex interfere with normal
biological processes in favor of bacterial survival via arresting metabolism, cell growth and cell division (dashed gray pathways are best understood for the E. coli
model, but not or partially characterized in P. aeruginosa). In E.coli, (p)ppGpp signaling is linked to toxin (T)-antitoxin (A) system via activation of the Lon protease
leading to the formation of persisters displaying dormant and antibiotic resistance phenotypes (dashed orange line). Generally, the TA complex is stable under normal
conditions suppressing toxin activity and further expression of cognate genes. Upon antitoxin degradation, toxin becomes active to hinder biological processes. In the
case of P. aeruginosa HigB/A, HicA/B, the toxin components perform endoribonuclease (RNase) activity on mRNA molecules. In P. aeruginosa, the (p)ppGpp
alarmone is linked to the production of ROS scavengers probably via QS or RpoS regulators and Lon activity is required for biofilm formation, motility, virulence and
antibiotic resistance. Furthermore, the TA system downregulates biofilm formation and virulence factor production while T3SS (type 3 secretion system) can be found
upregulated. Although, the (p)ppGpp signaling, Lon protease activity and TA modules (i.e., HigB/A, HicA/B, and likely more complexes) are present in P. aeruginosa,
their link to resistance to antibiotics and other stresses is poorly understood. AA, amino acids; QS, quorum sensing; RNAP, RNA polymerase. CM, cytoplasmic
membrane; OM, outer membrane.
To date five types (I-V) of TA systems have been described
in bacteria based on the nature and mode of action of antitoxin
(Wang et al., 2012). So far, HigB/HigA and HicA/HicB TA
modules encoded by genomic loci have been experimentally
demonstrated in P. aeruginosa, while other TA systems such
as the relBE and parDE loci were predicted but they have not
been characterized, yet (Pandey and Gerdes, 2005; Fernández-
García et al., 2016; Figure 5). The HigB/HigA and HicA/HicB
TA modules have been also widely reported for other bacteria
(Pandey and Gerdes, 2005; Li G. et al., 2016; Wood and Wood,
2016).
These TA modules belong to the type II TA system where
both toxin (i.e., HigB/HicA) and antitoxin (i.e., HigA/HicB) are
proteins directly interacting with each other retaining the toxin
inactivated, such as inhibiting the RNase activity of HigB or HicA
(Christensen et al., 2001; Rocker and Meinhart, 2016; Figure 5).
The HigB/HigA TAmodule was found to influence P. aeruginosa
pathogenicity where toxin HigB was shown to reduce the
production of the virulence factors pyochelin, pyocyanin,
swarming, and impaired biofilm formation representing a novel
function for a TA systems (Wood and Wood, 2016; Figure 5).
Another study showed that the HigB/HigA TA module was
necessary for the ciprofloxacin induced persister formation by
P. aeruginosa. Concurrently, HigB overproduction upregulated
the expression of T3SS genes leading to the accumulation of T3SS
proteins in persisters as well as increasing bacterial cytotoxicity
against host immune cells (Li M.et al., 2016; Figure 5).
Furthermore, these TA systems have been shown to be highly
prevalent in the clinical strains (Pandey and Gerdes, 2005;
Williams et al., 2011; Li G. et al., 2016). It is believed that
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persisters are one of the main reasons for recurring and chronic
infections where persisters withstand antibiotic treatments and
spawn new infecting population upon removal of antibiotic
treatment (Lewis, 2007; Wang and Wood, 2011). They are
abundant in P. aeruginosa biofilms which is the hallmark of long-
term infections particularly in CF patients (Lewis, 2008; Mulcahy
et al., 2010).
P. aeruginosa RESISTANCE TO FOREIGN
DNA
Infection of bacteria with viruses or bacteriophages is a natural
phenomenon which can lead to bacterial lysis. Bacteria harness
various mechanisms to destroy such foreign DNAs leading to
resistance. The CRISPR (clustered regularly interspaced short
palindromic repeats)-Cas (CRISPR associated proteins) systems
form the only adaptive immune system in prokaryotic cells which
also mediates P. aeruginosa survival during viral invasions (Cady
et al., 2012; Bondy-Denomy and Davidson, 2014). A CRISPR
region is an array of multiple repeated sequences on the bacterial
genome or a plasmid ranging from 21 to 48 bp in length and
separated by 26 to 72 bp hypervariable spacers (Bhaya et al., 2011;
Cady et al., 2012). The cas locus encoding Cas proteins is located
in the vicinity of the CRISPR region (Bhaya et al., 2011). In
principle, the molecular mechanism is based on acquisition and
integration of small fragments of foreign DNAs such as derived
from viruses into the spacer regions between two adjacent repeats
within the CRISPR locus mediated by Cas proteins with nuclease
activity. Subsequently, the CRISPR region is transcribed resulting
in pre-CRISPR RNA (pre-crRNA) which undergoes hydrolysis
by endoribonucleases forming small CRISPR RNAs (crRNAs).
The mature crRNAs in association with a multiprotein complex
known as CASCADE (CRISPR-associated complex for antiviral
defense) recognizes invasive DNAs upon complementarity which
results in the initiation of the cleavage of the crRNA–foreign
DNA hybridization complex, mediating survival of bacteria after
viral infections while protecting themselves from lysis (Brouns
et al., 2008; Mojica et al., 2009; Deveau et al., 2010; Garneau
et al., 2010; Bhaya et al., 2011). The CRISPR-Cas systems have
been classified into three major types (I, II and III) and at least
11 subtypes (IA-F, IIA-C and IIIA-B) encoding distinct crRNA-
guided surveillance complexes (Makarova et al., 2011).
A study showed that 36% of tested P. aeruginosa clinical
isolates harbored CRISPR-Cas systems developing adaptive
immunity against various mobile genetic elements such as
temperate phages, prophages, pathogenicity island transposons
which were integrated into the genome (Cady et al., 2011).
Different studies demonstrated that the types I-F and I-E
CRISPR-Cas systems are naturally active in P. aeruginosa isolates
(Cady et al., 2012; Pawluk et al., 2014). A recent phylogenetic
study revealed the existence of the type I-C CRISPR-Cas system
in some isolates of P. aeruginosa (van Belkum et al., 2015).
On the other hand, the activity of CRISPR/Cas system can
be inhibited by anti-CRISPR/Cas genes harbored by phages
infecting P. aeruginosa which counteract the type I-F and I-
E systems (Bondy-Denomy et al., 2015; Maxwell, 2016). Also
it has been shown that phages producing anti-CRISPR activity
are closely related to each other and with high sequence
similarity to bacteriophage DMS3 (Bondy-Denomy et al., 2013).
Bacteriophage DMS3 was isolated from clinical isolates of P.
aeruginosa and it was shown to inhibit biofilm formation and
swarming motility, and P. aeruginosa cannot develop immunity
against it due to the lack of complementarity between crRNA
and protospacers of DMS3 genome (Budzik et al., 2004; Zegans
et al., 2009). Furthermore, the CRISPR-Cas systems show a
strong correlation with antibiotic resistance/susceptibility (van
Belkum et al., 2015). Additionally, the same study showed that
the CRISPR-Cas systems play an important role in shaping the
accessory genomes of globally distributed P. aeruginosa strains.
Accessory genome is referred to highly variable regions of the
genome versus a relatively invariable core genome. P. aeruginosa
accessory genome varies from strain to strain, ranging from
6.9 to 18.0% of the total genome, and is mainly comprised
of integrative and conjugative elements, replacement islands,
prophages and phage-like elements, transposons, insertion
sequences and integrons (Kung et al., 2010; Ozer et al., 2014).
According to this finding the CRISPR typing with regard to
the frequency of spacer integration and deletion between related
strains can potentially be used for identifying the lineage of
strains especially within outbreaks (van Belkum et al., 2015).
Overall, understanding of the CRISPR-Cas and anti-CRISPR-
Cas systems is gradually becoming important in the context of
pathogenesis and strain lineage identification. These links were
highlighted by the discovery of the interaction of bacteriophage
DMS3 and the type I-F CRISPR, and its impact on biofilms
(Zegans et al., 2009; Palmer and Whiteley, 2011) as well as the
role of different CRISPR/Cas systems on virulence and antibiotic
resistance (Louwen et al., 2014). Overall, these findings suggest a
more diverse function of CRISPR/Cas systems within the context
of pathogenesis, requiring further in depth studies to elucidate
the underlying molecular mechanisms.
CONCLUSIONS AND PERSPECTIVES
For many years, P. aeruginosa has been a model organism and
received much attention from scientific community to study
the bacterial lifestyle and pathogenesis. It always has been of
particular importance due to causing persistent infections in CF
and immunocompromised patients. Nowadays, this ubiquitous
bacterial pathogen is accepted worldwide as a public health risk
due to its increasing prevalence in healthcare acquired infections
combined with its ability to develop resistances to multiple
classes of antibiotics. Over the past decade, extensive research
studies have focused on these growing concerns aiming at
deciphering the nature of P. aeruginosa capability and underlying
molecular mechanisms applying different modes of persistence
and antibiotic resistance.
In this review, we summarized several of the well characterized
molecular mechanisms which enable P. aeruginosa to survive
various hostile conditions such as during pathogenesis and
antibiotic treatment. These mechanisms form multiple layers of
physiological adaptations correlating with social behavior and
lifestyle of bacteria while responding environmental stimuli. Such
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extraordinary adaptive capability relies on extensive numbers of
regulatory or controlling factors within integrated and complex
signal processing pathways. These enable bacteria perceive and
process environmental cues in order orchestrate physiological
changes to promote adaptation to unfavorable conditions. Many
of these regulatory pathways, their cognate player, their signals
and how they are integrated with global regulatory networks still
remain poorly understood.
Furthermore, we highlighted key molecular pathways driving
P. aeruginosa survival and persistence at different stages of
pathogenesis such as QS elements for virulence traits, cyclic di-
GMP signaling in biofilm formation and development of chronic
traits, (p)ppGpp signaling/TA system in persister formation and
various strategic adaptations for developing resistance to divers
classes of antibiotics.
Recent technological advances in genomic characterization
of pathogens have provided invaluable information about the
dynamics of P. aeruginosa populations and their heterogeneity
at different stages of pathogenesis. These results which were
explained under “adaptive radiation” term emphasized that this
species shows a stunning capability to become resilient during
pathogenesis to withstand antibacterial treatment.
Available information indicated that sole therapy which only
relies on bacteriostatic/bactericidal compounds can readily be
defeated by bacterial resiliency and a management program
is still required to combat infections. This program should
be able to predict and evaluate physiological adaptations at
each stage of infection for exerting appropriate treatments
which could interfere with adaptation rather than increasing
the chance of bacterial survival. A good example is improper
and frequent application of antibiotics which must be avoided.
Instead a comprehensive hygiene program must be applied in
healthcare settings and among personnel to stop the spread of
nosocomial infections specifically caused by multidrug resistance
strains. Also, further research on identification of new drugs and
developing new alternative prevention and treatment strategies
for interfering with key regulatory pathways is needed.
At the end we suggest all efforts should consider international
coordinated multidisciplinary programs with results of
laboratory outputs being deposited in centralized accessible
databases to expedite advances in control of infections and
its implementation into clinical settings. The steadily growing
concern of emerging antibiotic resistance strains in the world,
would justify the set-up of such databases which then allow
developing world-wide guidelines for monitoring and recording
antibiotic resistance cases around the world. This should provide
healthcare experts with appropriate guidelines for well managing
bacterial infections and preventing the rate and spread of
resistance strains.
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